Instituto para el Desarrollo Biotecnológico y la Innovación

Instituto para el Desarrollo Biotecnológico y la Innovación (IDBI) is a Chilean biotechnology company specializing in regenerative medicine and advanced cell therapies. The company operates primarily through its clinical-stage research and its brand Inbiocriotec, which focuses on the development of tissue engineering products derived from amniotic membranes and mesenchymal stem cells. Its lead candidate, InbioDerm+C, is a cellularized scaffold designed for the treatment of complex chronic wounds such as diabetic foot ulcers. IDBI maintains strong ties with academic institutions, including the Universidad de Santiago de Chile and the Universidad de Valparaíso, to bridge the gap between basic research and clinical application. The company also provides specialized biobanking and cryopreservation services for biological tissues and cells.